They have dismantled a factory that made injections labelled as containing tirzepatide, the ingredient in Eli Lilly's ...

"This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and ...

Dr Reddy's Laboratories has received approval to manufacture and market generic semaglutide, a weight loss drug, once Novo Nordisk's patent expires in 2026.

The company is banking on key new launches, including weight loss drug Semaglutide and biosimilar Abatacept to drive growth ...

In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the ...

Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...

Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) seized the world's largest cache of unlicensed ...

The EMA is working with social media content creators to try to encourage "safe and responsible" use of weight-loss drugs.

Eli Lilly and Co. LLY has surged into the top decile of quality rankings among S&P 500 peers, achieving a percentile score of ...

Eli Lilly's rival Novo Nordisk plans to retail both Ozempic and Wegovy in India as diabetes and weight-loss drugs, ...

Shares of Eli Lilly and Novo Nordisk fell Friday, Oct. 17 after Pres. Donald Trump said the price of the weight-loss drug Ozempic could soon drop to $150 a month.